1.	Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000675520, NCCTG-N09C6, N09C6, NCT01156142
2.	CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687
3.	Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer Phase: Phase III Type: Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 201207059, NCT01687413
4.	A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 90 Sponsor: Other Protocol IDs: J08101, CA180123, NCT00882583
5.	Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 603EUSA03, NCT00901732
6.	Vitamin D - Celecoxib Therapy Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: CLIN-003-09S, NCT00953849
7.	Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx Phase: Phase II, Phase I Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J0988, NA_00026771, NA_00026771, NCT01088802
8.	Symptom Burden in Head and Neck Cancer Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2009-0517, NCT01219673
9.	Phase II Trial Evaluating Elimination of Radiation Therapy Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 07-0142 / 201106342, NCT00593840
10.	Preoperative Treatment With Cetuximab and/or IMC-A12 Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0342, NCT00957853
11.	Preoperative Soy Isoflavone Supplementation in the Prevention of Head and Neck Squamous Carcinoma Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 19 to 80 Sponsor: Other Protocol IDs: UMCC 2009.008, HUM%26957, NCT01028001
12.	A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J09100, NA_00031401, NCT01088789
13.	Minocycline in Oropharynx Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2010-0096, NCT01173692
14.	Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: ENT0033, SU-08222011-8290, 22329, NCI-2011-03271, NCT01437449
15.	De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LCCC1120, NCT01530997
16.	Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 andover Sponsor: Other Protocol IDs: IRB00008071, CPC-12095-L, NCI-2012-02780, NCT01748942
17.	A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and over Sponsor: NIDCR, Other Protocol IDs: J1247, 2P50DE019032, NA_00073880, NCT01697800
18.	INDUCTION CHEMOTHERAPY FOLLOWED BY CETUXIMAB AND RADIATION THERAPY FOR HEAD AND NECK CANCER Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 19834, NCT01467115
19.	Vaccine Therapy in Treating Patients With Head and Neck Cancer Phase: Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000515081, PCI-03-156, PCI-0507062, NCT00404339
20.	Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: HP-41372, UMGCC 0804, NCT00704041
21.	Anatomical Relationship of Level IB Lymph Nodes to the Submandibular Gland in Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RON-SCCI 08-003-1, NCT00728130
22.	Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000635094, BUMC-H-26649, H-26649, NCT00851253
23.	MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654169, UPCC-808258, 808258, NCT00984074
24.	Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System Phase: Phase I Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CCCWFU 60209, NCT01059357
25.	Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC Phase: Phase I Type: Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: MCC 13222, NCI-2010-02340, P30CA016059, NCT01283178